FIELD: medicine.
SUBSTANCE: group of inventions relates to the treatment of Wilson’s disease. A method for the treatment of Wilson’s disease in a patient who needs it includes taking 15 mg of bis-choline tetrathiomolybdate once a day, while bis-choline tetrathiomolybdate is taken on an empty stomach. Other options of a method for the treatment of Wilson’s disease in a patient, methods for changing a scheme of taking bis-choline tetrathiomolybdate for a patient with Wilson’s disease, a method for taking bis-choline tetrathiomolybdate for the treatment of a patient with Wilson’s disease, and the use of a composition containing bis-choline tetrathiomolybdate in a method for the treatment of Wilson’s disease in a patient are also disclosed.
EFFECT: group of inventions provides improvement of Cu metabolism, reduction in a concentration of toxic Cu, and maintenance of a normal Cu concentration to improve symptomatology in patients, and it does not have side effects.
87 cl, 19 dwg, 12 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF COMPONENTS FOR PREVENTION AND TREATMENT OF INDISPOSITION | 2011 |
|
RU2646830C2 |
| METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY | 2013 |
|
RU2667968C2 |
| ACTIVE INGREDIENT OF MEDICINAL AGENT, MEDICINAL AGENT, PHARMACEUTICAL CONPOSITION AND METHOD OF DEMENT SYNDROME TREATMENT | 2007 |
|
RU2327480C1 |
| THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES | 2018 |
|
RU2763425C2 |
| METHODS FOR TREATMENT OF EOSINOPHILIC ESOPHAGITIS | 2017 |
|
RU2766577C2 |
| RECOGNITION IMPROVEMENT | 2012 |
|
RU2638809C2 |
| RAPID REDUCTION OF MOTOR FLUCTUATIONS ACCOMPANYING PARKINSON'S DISEASE | 2014 |
|
RU2698330C2 |
| KOBITOLIMOD FOR USE IN TREATMENT OF INFLAMMATORY BOWEL DISEASE | 2018 |
|
RU2766356C2 |
| THERAPEUTIC AGENTS FOR THE TREATMENT OF RESTLESS LEG SYNDROME | 2019 |
|
RU2802288C2 |
| TREATMENT OF ESSENTIAL TREMOR, USING (R)-2-(4-ISOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUORETHOXY)PYRIDINE-2-YL)ETHYL)ACETAMIDE | 2019 |
|
RU2780318C1 |
